
Producing vaccines and deploying them to the world’s population in the midst of a pandemic would be a massive challenge even if researchers are able to deliver one-dose inoculations. A need for two would make manufacturing and logistics even more complex.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hjvIEw
via
IFTTT
0 comments:
Post a Comment